ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

165
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
16 Sep 2024 00:41

Merger Arb Mondays (16 Sep) - China TCM, Canvest, GA Pack, Raysum, Seven & I, Fuji Soft, Dyna-Mac

This week, the highest gross spreads are HEC Pharma (139.1%), Raysum (94.2%), Canvest (8.4%), GAPack (7.3%), China TCM (6.5%), Henlius (6.3%),...

Logo
538 Views
Share
10 Sep 2024 08:55

Shanghai Henlius Biotech (2696.HK) Privatization Update - Some New Information Worth the Attention

Fosun Pharma will make every effort to promote the success of privatization due to plans for Henlius internal integration with Fosun Pharma and...

Logo
495 Views
Share
09 Sep 2024 00:39

Merger Arb Mondays (09 Sep) - Shinko, Fuji Soft, Pasco, GA Pack, CPMC, Latin Res, Capitol, PSC, Rex

This week, the highest gross spreads are HEC Pharma (116.0%), Canvest (8.4%), Shinko Electric (7.9%), Malaysia Airports (7.4%), GA Pack (6.9%),...

Logo
339 Views
Share
08 Sep 2024 09:12

China Healthcare Weekly (Sep.8) - Fosun Pharma, Medical Device Outlook, Biotech Investment Criteria

Business model of medical devices is shifting, leading to potential underperformance. There's a gap between Chinese Biotech and top players....

Logo
318 Views
Share
02 Sep 2024 00:33

Merger Arb Mondays (02 Sep) - Canvest, China TCM, GA Pack, CPMC, Shinko, Arvida, SilverLake

This week, the highest gross spreads are HEC Pharma (109.7%), Canvest (13.7%), China TCM (8.5%), Malaysia Airports (7.8%), GA Pack (7.3%), Henlius...

Logo
341 Views
Share
x